PNC Financial Services Group’s Biocept, Inc. BIOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-167
Closed -$21K 4456
2021
Q2
$21K Buy
+167
New +$22.6K ﹤0.01% 3457
2020
Q1
Hold
0
4110
2019
Q4
Hold
0
4146
2019
Q3
Hold
0
4148
2019
Q2
Hold
0
4175
2019
Q1
Hold
0
4163
2018
Q4
Hold
0
4226
2018
Q3
Hold
0
4280

Other funds holding BIOC

PNC Financial Services Group's BIOC Position: Q3 2021 in Review

PNC Financial Services Group sold out of Biocept, Inc. (BIOC) in Q3 2021, closing a stake of 167 shares — an estimated $21K sold.

PNC Financial Services Group first reported a position in BIOC in Q2 2021 and held it in 1 quarter. The position peaked at $21K in Q2 2021. 26 funds tracked by Wall St. Rank hold BIOC as of Q3 2021.

  • PNC Financial Services Group reported no remaining Biocept, Inc. position as of Q3 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 167 Biocept, Inc. shares in Q3 2021, an estimated $21K.
  • PNC Financial Services Group first reported a position in Biocept, Inc. in Q2 2021 and held it in 1 quarter.
  • PNC Financial Services Group's Biocept, Inc. position peaked at $21K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2021.

Based on PNC Financial Services Group's 13F filing for Q3 2021, filed 5 Nov 2021.